Group 1 - The core point of the announcement is that West Point Pharmaceuticals (301130) has set a preliminary inquiry transfer price of 24.69 yuan per share based on the inquiry subscription situation as of June 30, 2025 [1] - A total of 15 valid bids were received for the inquiry transfer, which included professional institutional investors such as fund management companies, securities companies, and private equity fund managers [1] - The total number of shares effectively subscribed by participating institutional investors reached 3.72 million shares, resulting in an effective subscription multiple of 4.86 times [1] Group 2 - The shares intended for transfer have been fully subscribed, with the preliminary determination of the transferees being five institutional investors [1] - The total number of shares to be transferred to the selected institutional investors is 765,000 shares [1]
西点药业：股东询价转让定价为24.69元/股